Key Details
- Symbol (NSE): EXPLEOSOL
- Sender: S. Sampath Kumar, Company Secretary & Compliance Officer (M. No. FCS 3838)
Event Details
- A meeting of the Board of Directors of the Company is scheduled to be held on Monday, July 27, 2026.
- The agenda for the meeting includes, inter-alia, to consider Dividend, if any, for the Financial Year 2025-26.